Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Dividends Paid - Common (2019 - 2025)

Pharma-Bio Serv filings provide 7 years of Dividends Paid - Common readings, the most recent being $1.7 million for Q2 2025.

  • On a quarterly basis, Dividends Paid - Common changed 0.13% to $1.7 million in Q2 2025 year-over-year; TTM through Oct 2025 was $1.7 million, a 50.07% decrease, with the full-year FY2025 number at $1.7 million, changed 0.13% from a year prior.
  • Dividends Paid - Common hit $1.7 million in Q2 2025 for Pharma-Bio Serv, roughly flat from $1.7 million in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $1.7 million in Q2 2021 to a low of $2069.0 in Q4 2021.
  • Median Dividends Paid - Common over the past 5 years was $1.7 million (2022), compared with a mean of $1.5 million.
  • Biggest five-year swings in Dividends Paid - Common: dropped 0.18% in 2022 and later decreased 0.02% in 2023.
  • Pharma-Bio Serv's Dividends Paid - Common stood at $2069.0 in 2021, then skyrocketed by 83235.14% to $1.7 million in 2022, then decreased by 0.02% to $1.7 million in 2023, then decreased by 0.09% to $1.7 million in 2024, then fell by 0.13% to $1.7 million in 2025.
  • The last three reported values for Dividends Paid - Common were $1.7 million (Q2 2025), $1.7 million (Q2 2024), and $1.7 million (Q1 2024) per Business Quant data.